In this podcast episode, Dr Nester and Dr Andrew Bomback discuss current strategies and key unmet needs in the treatment of C3G. Dr Bomback explores investigational approaches to target the underlying cause of disease pathophysiology, including complement inhibition, and the importance of patient access to clinical trials. Both experts then close the podcast with a discussion on wish list items that would help to address these needs and other treatment challenges in the future.

In the first episode of the complement-mediated kidney diseases podcast series, Dr Nester explores key challenges in the differential diagnosis of C3G with Dr Christoph Licht. Learn about the importance of renal biopsy, and key challenges in differentiating C3G from other glomerulopathies in clinical practice.

To listen, click play below.